| BRISTOL-MYERS SQUIBBDL-10 |
| USA |
| Gesundheit |
| US1101221083 / 850501 |
| BRM (Frankfurt) / BMY (NYSE) |
| FRA:BRM, ETR:BRM, BRM:GR, NYSE:BMY |
| S&P500 |
| https://www.bms.com/ |
|
Bristol-Myers Squibb Company is a leading biopharmaceutical firm engaged in the discovery, development, licensing, manufacture, marketing, distribution, and sale of innovative medicines worldwide. It ..
>Volltext.. |
| 104543.56 Mio. EUR |
| 135665.59 Mio. EUR |
| 40732.09 Mio. EUR |
| 16252.6 Mio. EUR |
| 5961.82 Mio. EUR |
| 2.93 EUR |
| 39840.43 Mio. EUR |
| 8628.33 Mio. EUR |
| 11964.22 Mio. EUR |
| 0.46 |
| -12.05% |
| - |
| 2.13 EUR |
| 4.1% |
| 4.15% |
| 02.01.26 - 0.5355€ 03.10.25 - 0.53196€ >weitere anzeigen... |
| - |
| BRISTOL-MYERS, BRISTOL MYERS |
| 18.02.26 |
|